SMA Solar (S92) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Q1 2026 sales rose 4.0% year-over-year to €340.9 million, driven by growth in Home & Business Solutions, with inverter output up 7.9% to 4,448 MW.
EBITDA increased to €26.1 million (7.7% margin), up from €24.6 million (7.5%) in Q1 2025, despite restructuring-related expenses and one-time effects.
Order backlog reached €1,414.5 million, with strong contributions from both Home & Business Solutions and Large Scale & Project Solutions.
Net income fell to -€1.6 million from €5.5 million year-over-year, mainly due to deferred tax expenses.
Negative free cash flow of €-27 million, mainly due to restructuring and higher net working capital.
Financial highlights
Gross margin improved to 25.7% from 24.2% year-over-year.
Operating profit (EBIT) rose to €13.3 million (3.9% margin) from €11.4 million (3.5%).
Net cash position at €148.2 million, down from €176.4 million at year-end 2025.
Equity ratio slightly increased to 28.4% from 28.0% at year-end 2025.
Capital expenditure dropped sharply to €6.3 million from €65.7 million in Q1 2025.
Outlook and guidance
FY 2026 sales and EBITDA expected in the upper third of €1,475–1,675 million and €50–180 million guidance, respectively.
Home & Business Solutions division forecasted to see significant sales growth but remain loss-making, with improved EBIT.
Large Scale & Project Solutions division expected to see slightly higher sales but lower EBIT due to higher costs.
Guidance includes potential refunds from IEEPA tariffs deemed unlawful.
Forecast subject to changes in trade restrictions, geopolitical tensions, tariffs, and currency effects.
Latest events from SMA Solar
- 2025 revenue was flat, losses deepened on one-offs, but cash flow and 2026 outlook improved.S92
Q4 202526 Mar 2026 - Large Scale growth offsets Home and C&I declines; cash flow and outlook remain pressured.S92
Q2 20242 Feb 2026 - Sharp sales and earnings drop, major restructuring, but Large Scale segment outperforms.S92
Q3 202414 Jan 2026 - 2024 sales and EBITDA declined, but restructuring aims for recovery and EBIT improvement in 2025.S92
Q4 202424 Dec 2025 - Large Scale growth offset weak Home and C&I, with cautious outlook amid tariff and market risks.S92
Q1 202525 Nov 2025 - Sales and margins fell in H1 2025, but cash flow and restructuring efforts improved outlook.S92
Q2 202523 Nov 2025 - Large Scale growth offset by HBS losses and major restructuring; outlook remains challenging.S92
Q3 202517 Nov 2025 - Revenue and earnings fell sharply in 2024, driving a renewed focus on efficiency and innovation.S92
AGM 2025 Presentation1 Jul 2025